Correlation Between Apogee Therapeutics, and Palatin Technologies
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Palatin Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Palatin Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Palatin Technologies, you can compare the effects of market volatilities on Apogee Therapeutics, and Palatin Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Palatin Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Palatin Technologies.
Diversification Opportunities for Apogee Therapeutics, and Palatin Technologies
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Apogee and Palatin is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Palatin Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palatin Technologies and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Palatin Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palatin Technologies has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Palatin Technologies go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and Palatin Technologies
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 0.77 times more return on investment than Palatin Technologies. However, Apogee Therapeutics, Common is 1.3 times less risky than Palatin Technologies. It trades about 0.28 of its potential returns per unit of risk. Palatin Technologies is currently generating about -0.17 per unit of risk. If you would invest 4,836 in Apogee Therapeutics, Common on June 24, 2024 and sell it today you would earn a total of 1,007 from holding Apogee Therapeutics, Common or generate 20.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Apogee Therapeutics, Common vs. Palatin Technologies
Performance |
Timeline |
Apogee Therapeutics, |
Palatin Technologies |
Apogee Therapeutics, and Palatin Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apogee Therapeutics, and Palatin Technologies
The main advantage of trading using opposite Apogee Therapeutics, and Palatin Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Palatin Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palatin Technologies will offset losses from the drop in Palatin Technologies' long position.Apogee Therapeutics, vs. HCW Biologics | Apogee Therapeutics, vs. RenovoRx | Apogee Therapeutics, vs. Scpharmaceuticals | Apogee Therapeutics, vs. Milestone Pharmaceuticals |
Palatin Technologies vs. HCW Biologics | Palatin Technologies vs. RenovoRx | Palatin Technologies vs. Scpharmaceuticals | Palatin Technologies vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |